Norihito Tokunaga

Years Active: 2020-2022
Publications (10 Years): 2

Takeda Pharmaceutical Company

Kyoto University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Takeda Pharmaceutical Company

Japan

Principal scientist, Medicinal chemist :: Research, Neuroscience Drug Discovery Unit, Drug Discovery Chemistry Laboratories

Education History

Kyoto University

Japan

PHD :: Department of Chemistry, Graduate School of Science

Publications

Tatsuhiko Fujimoto, Kentaro Rikimaru, Koichiro Fukuda, Hiromichi Sugimoto, Kei Masuda, Norio Ohyabu, Yoshihiro Banno, Norihito Tokunaga, Tetsuji Kawamoto, Yoshihide Tomata, Yasumi Kumagai, Motoo Iida, Yoichi Nagano, Mariko Yoneyama-Hirozane, Yuji Shimizu, Katsunori Sasa, Takashi Ishikawa, Hiroshi Yukitake, Mitsuhiro Ito, Kazunobu Aoyama, Takahiro Matsumoto
Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor Agonist. ACS medicinal chemistry letters 13 (3) (2022)
Shotaro Shibutani, Taiga Kodo, Mitsutaka Takeda, Kazunori Nagao, Norihito Tokunaga, Yusuke Sasaki, Hirohisa Ohmiya
Organophotoredox-Catalyzed Decarboxylative C(sp3)-O Bond Formation. Journal of the American Chemical Society 142 (3) (2020)

Norihito Tokunaga.css-eqlu8i{font-size:small;padding-left:4px;}